Association of Bone Metastatic Burden With Survival Benefit From Prostate Radiotherapy in Patients With Newly Diagnosed Metastatic Prostate Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Ali A, Hoyle A, Haran ÁM, Brawley CD, Cook A, Amos C, Calvert J, Douis H, Mason MD, Dearnaley D, Attard G, Gillessen S, Parmar MKB, Parker CC, Sydes MR, James ND, Clarke NW.
JAMA Oncol. 2021 Apr 1;7(4):555-563. doi: 10.1001/jamaoncol.2020.7857.
Metastatic Prostate Cancer.
Sartor O, de Bono JS.
N Engl J Med. 2018 Feb 15;378(7):645-657. doi: 10.1056/NEJMra1701695. Epub 2018 Feb 7.
Regulation of prostate cancer progression by the tumor microenvironment.
Shiao SL, Chu GC, Chung LW.
Cancer Lett. 2016 Sep 28;380(1):340-8. doi: 10.1016/j.canlet.2015.12.022. Epub 2016 Jan 28.
Treatment of the Primary Tumor in Metastatic Hormone-sensitive Prostate Cancer: Not Yet Ready for Prime Time as the Standard of Care.
Ranasinghe WKB, Reichard CA, Chapin BF.
Eur Urol. 2019 Nov;76(5):543-545. doi: 10.1016/j.eururo.2019.06.014. Epub 2019 Jun 25.
miRNA-877-5p inhibits malignant progression of prostate cancer by directly targeting SSFA2.
Wang W, Yi J, Dong D, Mao W, Wang X, Yan Z.
Eur J Histochem. 2021 Sep 20;65(3):3243. doi: 10.4081/ejh.2021.3243.
The role of metastasis-directed therapy and local therapy of the primary tumor in the management of oligometastatic prostate cancer.
Kim J, Park JS, Ham WS.
Investig Clin Urol. 2017 Sep;58(5):307-316. doi: 10.4111/icu.2017.58.5.307. Epub 2017 Aug 8.
Ezrin expression in circulating tumor cells is a predictor of prostate cancer metastasis.
Chen Z, Wang J, Lu Y, Lai C, Qu L, Zhuo Y.
Bioengineered. 2022 Feb;13(2):4076-4084. doi: 10.1080/21655979.2021.2014710.
Application of Primary/Secondary Circulating Tumor Cells for the Prediction of Biochemical Recurrence in Nonmetastatic Prostate Cancer Patients following Radical Prostatectomy or Radiotherapy: A Meta-Analysis.
Cao L, Hao P, Lin D, Li Y, Hu T, Cai T, Cui S, Wu T.
Biomed Res Int. 2021 Sep 20;2021:4730970. doi: 10.1155/2021/4730970. eCollection 2021.
Prognostic significance of tumor grade and stage in the patient with carcinoma of the prostate.
Grayhack JT, Assimos DG.
Prostate. 1983;4(1):13-31. doi: 10.1002/pros.2990040103.
Canine prostatic carcinoma.
Axiak SM, Bigio A.
Compend Contin Educ Vet. 2012 Oct;34(10):E1-5.
